SVB Wealth’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,424
| Closed | -$217K | – | 916 |
|
|
2023
Q2 | $217K | Sell |
5,424
-26
| -0.5% | -$1.07K | ﹤0.01% | 796 |
|
|
2023
Q1 | $222K | Buy |
5,450
+127
| +2% | +$5.05K | ﹤0.01% | 844 |
|
|
2022
Q4 | $206K | Sell |
5,323
-5
| -0.1% | -$243 | ﹤0.01% | 903 |
|
|
2022
Q3 | $283K | Buy |
5,328
+324
| +6% | +$18K | ﹤0.01% | 718 |
|
|
2022
Q2 | $292K | Buy |
5,004
+4
| +0.1% | +$262 | ﹤0.01% | 576 |
|
|
2022
Q1 | $382K | Hold |
5,000
| – | – | 0.01% | 514 |
|
|
2021
Q4 | $301K | Hold |
5,000
| – | – | ﹤0.01% | 578 |
|
|
2021
Q3 | $280K | Hold |
5,000
| – | – | ﹤0.01% | 812 |
|
|
2021
Q2 | $303K | Hold |
5,000
| – | – | ﹤0.01% | 751 |
|
|
2021
Q1 | $350K | Hold |
5,000
| – | – | ﹤0.01% | 630 |
|
|
2020
Q4 | $299K | Hold |
5,000
| – | – | ﹤0.01% | 623 |
|
|
2020
Q3 | $301K | Hold |
5,000
| – | – | 0.01% | 522 |
|
|
2020
Q2 | $262K | Buy |
+5,000
| New | +$209K | ﹤0.01% | 486 |
|
|
2020
Q1 | – | Sell |
-5,000
| Closed | -$227K | – | 664 |
|
|
2019
Q4 | $227K | Buy |
+5,000
| New | +$212K | ﹤0.01% | 551 |
|
|
2019
Q3 | – | Sell |
-5,000
| Closed | -$217K | – | 523 |
|
|
2019
Q2 | $217K | Buy |
+5,000
| New | +$212K | 0.01% | 490 |
|
|
2019
Q1 | – | Sell |
-5,000
| Closed | -$215K | – | 411 |
|
|
2018
Q4 | $215K | Hold |
5,000
| – | – | 0.01% | 373 |
|
|
2018
Q3 | $246K | Buy |
+5,000
| New | +$216K | 0.01% | 394 |
|
|
2018
Q2 | – | Sell |
-7,075
| Closed | -$220K | – | 457 |
|
|
2018
Q1 | $220K | Buy |
7,075
+350
| +5% | +$12.5K | 0.01% | 414 |
|
|
2017
Q4 | $307K | Buy |
6,725
+75
| +1% | +$2.97K | 0.01% | 389 |
|
|
2017
Q3 | $250K | Hold |
6,650
| – | – | 0.01% | 414 |
|
|
2017
Q2 | $317K | Buy |
+6,650
| New | +$309K | 0.01% | 400 |
|
Other funds holding PCRX
FCM
SIMG
PM